DAY 3 - Monday, Feb. 10, 2014

ANNUAL GLAUCOMA SYMPOSIUM

Keynote Lecture: Future of teaching,
practice of medicine begins today

When it comes to the teaching and practice of medicine, what is the future of the United States health-care system and how will physicians arrive there? Michael V. Drake, MD, current chancellor of the University of California, Irvine, and soon-to-be president of The Ohio State University, Columbus, addressed these concerns in the Shaffer-Hetherington-Hoskins Lecture during the Glaucoma 360 CME Symposium. » MORE

Managing the odds for good
outcomes in glaucoma

To ensure good outcomes for patients with glaucoma, Andrew G. Iwach, MD, recommended beginning the treatment process with the best IOP-lowering medications that best suit those patients. Dr. Iwach, associate clinical professor of ophthalmology, University of California, San Francisco, offered his suggestions at the Glaucoma 360 CME Symposium, where he also served as program moderator. » MORE

New devices and technology
take IOP monitoring to next level

Though monitoring IOP in patients with glaucoma is important, it is fairly well established that the higher the IOP, the greater the chance of glaucoma disease progression. Ophthalmologists now need to track peak IOPs, daily variability of pressure, patient body position, and effects of therapy, said L. Jay Katz, MD, director of Glaucoma Services, Wills Eye Institute, Philadelphia, and professor of ophthalmology, Thomas Jefferson University. » MORE

Who's at risk? Reviewing
factors for glaucoma onset

As ophthalmologists, it is imperative to review the potential risk factors for glaucoma and what medicine knows about them, noted Shan C. Lin, MD, a member of the ophthalmology department at the University of California San Francisco School of Medicine. » MORE